Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001358001 | SCV003262149 | benign | not provided | 2022-08-09 | criteria provided, single submitter | clinical testing | |
Casey Eye Institute Glaucoma Genetics Lab | RCV000086413 | SCV000118560 | not provided | Glaucoma 1, open angle, F | no assertion provided | not provided | ||
Department of Pathology and Laboratory Medicine, |
RCV001358001 | SCV001553624 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The ASB10 p.R244H variant was not identified in the literature but was identified in dbSNP (ID: rs104886476) and in ClinVar (classification not provided by Casey Eye Institute Glaucoma Genetics Lab). The variant was identified in control databases in 117 of 280842 chromosomes (1 homozygous) at a frequency of 0.0004166, and was observed at the highest frequency in the East Asian population in 98 of 19898 chromosomes (1 homozygous) (freq: 0.004925) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.R244 residue is not conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |